NCT06968637

Brief Summary

The goal of this clinical trial is to determine whether integration of vision care into the DM treatment system, by providing specific recommendations to doctors for management of diabetes alongside feedback on positive eye exams for DR can improve diabetes care outcomes. The main questions it aims to answer are:

  1. 1.Does delivery of specific diabetes management recommendations to diabetes doctors for patients of theirs found to have DR lead to significantly improved blood glucose control as indicated by % reaching WHO targets of HbA1c (or targets for blood sugar if HbA1c data are unavailable)?
  2. 2.What is the cost-effectiveness of the intervention, measured as total intervention cost per additional participant reaching the WHO target?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
336

participants targeted

Target at P75+ for not_applicable diabetes-mellitus

Timeline
6mo left

Started Aug 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Aug 2025Dec 2026

First Submitted

Initial submission to the registry

May 5, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

August 25, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

September 11, 2025

Status Verified

September 1, 2025

Enrollment Period

1.3 years

First QC Date

May 5, 2025

Last Update Submit

September 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The proportion of participants reaching WHO target HbA1c levels of <= 7.0% (or WHO blood sugar targets if HbA1c data are unavailable) among participants with any DR, upon chart review by a masked clinician observer, compared between study groups.

    According to the World Health Organization (WHO), the specific HgA1c target is \<= 7.0%

    From enrollment to chart review (3 months after enrollment)

Secondary Outcomes (1)

  • Cost-effectiveness, measured as total intervention cost per additional patient meeting the WHO blood sugar target.

    Enrollment to chart review (3 months after enrollment)

Study Arms (2)

Control Group: Only DR results provided

NO INTERVENTION

For these participants, the patient information system (PIS) will send only diabetic retinopathy (DR) results to the Diabetologist at the diabetic hospital without specific care recommendations

Intervention Group: DR results + care recommendations for DM management provided

EXPERIMENTAL

For these participants, the patient information system (PIS) will send DR results to the Diabetologist at the diabetic hospital along with specific care recommendations for diabetes management (only for those patients with ANY DR)

Other: care recommendations

Interventions

Provision of specific care recommendations for diabetes management. Based on existing guidelines, when any DR is present, the PIS will prompt diabetologists to check, and if necessary, change medicines to optimize, blood sugar, blood pressure and lipids.

Also known as: Specific DM care recommendations
Intervention Group: DR results + care recommendations for DM management provided

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with DM
  • Diagnosed with DR in at least one eye
  • Over 30 years of age
  • Currently treated at the Dinajpur Diabetes Hospital and Gausul Azam BNSB Eye Hospital in Bangladesh
  • willingness to participate in the study

You may not qualify if:

  • Any ocular condition impairing the view of the fundus sufficiently to preclude grading of the image for DR.
  • Inability to comply with retinal photography to the extent that a gradable image cannot be captured, or any other factor leading to absence of sufficient images to grade at least one eye of a participant.
  • Medical conditions that could impair compliance with follow-up (such as stroke, dementia, etc.)
  • Unwilling to participate in the study, or incapable of giving informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dinajpur Diabetes & Swasthoseba Hospital

Dinajpur Sadar, Dinajpur, 5200, Bangladesh

RECRUITING

Gausul Azam BNSB Eye Hospital

Dinajpur District, Bangladesh

RECRUITING

MeSH Terms

Conditions

Diabetes MellitusDiabetic Retinopathy

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesRetinal DiseasesEye DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesDiabetes Complications

Study Officials

  • Munir Ahmed

    Orbis Bangladesh

    PRINCIPAL INVESTIGATOR
  • Nathan Congdon

    Orbis

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Cluster-randomised design, with diabetologist as the cluster. In the intervention group, a Patient Information System (PIS) database will be used, both at the diabetic hospital and eye hospital in Dinajpur. The PIS will be used for referral tracking, to deliver the results of the eye exam to the diabetologist, and, most importantly, based on the result of the DR exam, to provide specific care recommendations for diabetes management. Based on existing guidelines, when DR is present, the PIS will prompt diabetologists to check, and if necessary, change medicines to optimize, blood sugar, blood pressure and lipids. Therefore, through the doctors of the diabetic hospital tracking eye results, the PIS will reinforce the need for the patient to visit both the eye hospital and diabetic hospital for DM/DR management and will improve overall DM care. In the Control group, information on the DR exam will be conveyed through the PIS without specific care recommendations.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2025

First Posted

May 13, 2025

Study Start

August 25, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

September 11, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

de-identified data will be shared upon reasonable request to the corresponding author

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations